News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Slideshows|June 12, 2021

Children’s Mental Health Response to COVID-19

Author(s)Leah Kuntz

What impact has the pandemic had on children's mental health?

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

Protecting Children From Chatbot Companions

ByAllen Frances, MD,Nathan Thoma, PhD,Mandy McLean, PhD

December 23rd 2025

adolescent psychiatry lifestyle medicine obesity

Youth Lifestyle Psychiatry: Addressing Obesity in the Psychiatric Setting

ByTiffani L. Bell Washington, MD, MPH, FAPA,Jessica Walters

November 26th 2025

ADHD NDA NDSRI child adolescent

New Drug Application Submitted for Centanafidine for Treatment of ADHD

ByJessica Walters

November 25th 2025

ADHD medication

Tolerance to Stimulant Medications in the Treatment of Children With ADHD

ByJames M. Swanson, PhD,Anthony A. Grace, PhD

November 21st 2025

electric brain

FDA Clears Deep Transcranial Magnetic Stimulation for Adolescents With MDD

November 14th 2025

Trending on Psychiatric Times

Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia

Research Recap From the European College of Neuropsychopharmacology Congress

AI in 2025: A Look Back With Allen Frances, MD

Breakage

Latest Alzheimer Disease Data: Reports from CTAD 2025